Bachem Investor Relations Material

Bachem Holding AG provides services to the pharmaceutical and biotechnology industries primarily in Switzerland, the United States, Germany, Ireland, the United Kingdom, Austria, Japan, and internationally. It offers peptides as active pharmaceutical ingredients (API) for the treatment of neuronal diseases and various forms of cancer; intermediates for the synthesis of API’s comprising cytotoxic agents to treat various cancers; bioanalytical services for the development or adaptation of assays using mass spectrometry technologies; and hapten labeled peptides for applications in diagnostics and research.